CA2743451A1 - Nucleosides modifies pour le traitement d'infections virales et de proliferations cellulaires anormales - Google Patents

Nucleosides modifies pour le traitement d'infections virales et de proliferations cellulaires anormales Download PDF

Info

Publication number
CA2743451A1
CA2743451A1 CA2743451A CA2743451A CA2743451A1 CA 2743451 A1 CA2743451 A1 CA 2743451A1 CA 2743451 A CA2743451 A CA 2743451A CA 2743451 A CA2743451 A CA 2743451A CA 2743451 A1 CA2743451 A1 CA 2743451A1
Authority
CA
Canada
Prior art keywords
beta
pharmaceutically acceptable
acceptable salt
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2743451A
Other languages
English (en)
Inventor
Lieven Stuyver
Kyoichi A. Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Pharmasset LLC
Original Assignee
Pharmasset Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasset Inc filed Critical Pharmasset Inc
Priority claimed from CA2426187A external-priority patent/CA2426187C/fr
Publication of CA2743451A1 publication Critical patent/CA2743451A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2743451A 2000-10-18 2001-10-18 Nucleosides modifies pour le traitement d'infections virales et de proliferations cellulaires anormales Abandoned CA2743451A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24148800P 2000-10-18 2000-10-18
US60/241,488 2000-10-18
US28215601P 2001-04-06 2001-04-06
US60/282,156 2001-04-06
CA2426187A CA2426187C (fr) 2000-10-18 2001-10-18 Nucleosides modifies pour le traitement des infections virales et de la proliferation cellulaire anormale

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2426187A Division CA2426187C (fr) 2000-10-18 2001-10-18 Nucleosides modifies pour le traitement des infections virales et de la proliferation cellulaire anormale

Publications (1)

Publication Number Publication Date
CA2743451A1 true CA2743451A1 (fr) 2002-04-25

Family

ID=44318823

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2743451A Abandoned CA2743451A1 (fr) 2000-10-18 2001-10-18 Nucleosides modifies pour le traitement d'infections virales et de proliferations cellulaires anormales

Country Status (1)

Country Link
CA (1) CA2743451A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2590198A (en) * 2017-12-07 2021-06-23 Univ Emory N4-hydroxycytidine and derivatives and anti-viral uses related thereto
US11628181B2 (en) 2014-12-26 2023-04-18 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11628181B2 (en) 2014-12-26 2023-04-18 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
GB2590198A (en) * 2017-12-07 2021-06-23 Univ Emory N4-hydroxycytidine and derivatives and anti-viral uses related thereto
GB2590198B (en) * 2017-12-07 2022-02-23 Univ Emory N4-hydroxycytidine derivatives and anti-viral uses related thereto
US11331331B2 (en) 2017-12-07 2022-05-17 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
US11903959B2 (en) 2017-12-07 2024-02-20 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto

Similar Documents

Publication Publication Date Title
CA2426187C (fr) Nucleosides modifies pour le traitement des infections virales et de la proliferation cellulaire anormale
AU2002228749A1 (en) Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
JP4931683B2 (ja) Ｒｎａ依存性ｒｎａウィルスポリメラーゼ阻害薬としてのヌクレオシド誘導体
EP2848624B1 (fr) Nucléosides substitués en position 2',4' en tant qu'agents antiviraux
IE902665A1 (en) Nucleoside derivatives and pharmaceutical compositions¹containing them
CA2451745A1 (fr) .beta.-2'-ou 3'-halonucleosides
EP1480982A2 (fr) Analogues de nucleoside fluores modifies
Van Aerschot et al. Synthesis and antiviral activity evaluation of 3′-fluoro-3′-deoxyribonucleosides: broad-spectrum antiviral activity of 3′-fluoro-3′-deoxyadenosine
CA2743451A1 (fr) Nucleosides modifies pour le traitement d'infections virales et de proliferations cellulaires anormales
TWI293306B (en) Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
Kisakürek Perspectives in nucleoside and nucleic acid chemistry
ES2357811T3 (es) Nucleósidos modificados para el tratamiento de infecciones virales y proliferación celular anormal.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20160303